Real Brands Announces Entry to Medical Psychedelics Market, Partners with Marcu & Arora for Licensure, R&D
March 24, 2022 08:01 ET
|
Real Brands Inc.
Real Brands applying for DEA psychedelics licensurePsychedelics drugs market size is projected to reach $10.75 billion by 2027Real Brands planning to leverage new clinical research to produce and...
Le Canada franchit une première étape vers une réglementation indispensable pour lutter contre la pollution plastique
May 12, 2021 10:47 ET
|
Oceana Canada; OCEANA CANADA, ENVIRONMENTAL DEFENCE, DAVID SUZUKI FOUNDATION, ECOJUSTICE, TORONTO ENVIRONMENTAL ALLIANCE
TORONTO, 12 mai 2021 (GLOBE NEWSWIRE) -- Les groupes de défense de l’environnement saluent la décision du gouvernement canadien d’ajouter les « articles manufacturés en plastique » à l’Annexe 1 de...
Canada takes first step toward much-needed regulatory action to address plastic pollution
May 12, 2021 10:47 ET
|
Oceana Canada; OCEANA CANADA, ENVIRONMENTAL DEFENCE, DAVID SUZUKI FOUNDATION, ECOJUSTICE, TORONTO ENVIRONMENTAL ALLIANCE
TORONTO, May 12, 2021 (GLOBE NEWSWIRE) -- Environmental groups applaud Canada's decision today to list “plastic manufactured items” on Schedule 1 under the Canadian Environmental Protection Act...
MedTainer Announces Re-Positioning; Level of Industry Interest Increases
March 04, 2019 08:30 ET
|
MedTainer Inc.
CORONA, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- MedTainer Inc. (MDTR-OTCMARKETS) announced that the company has begun to re-position in order to attract new and diverse levels of investment and...
MedTainer’s Record-Setting Pace Continues, Plans for Expansion Proceed
March 01, 2019 08:30 ET
|
MedTainer Inc.
CORONA, Calif., March 01, 2019 (GLOBE NEWSWIRE) -- MedTainer Inc. (MDTR-OTCMARKETS) announced today that orders for its signature product, the MedTainer™, have continued to rise and the company has...
Letter to Shareholders from Curt Fairbrother, CEO The Medtainer™
February 19, 2019 08:30 ET
|
MedTainer Inc.
CORONA, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Dear Shareholders- I know that you haven’t heard from us in a while, and I apologize for that. I assure you that it was not by omission but by...
AXIM Biotech Receives Schedule 1 Permit to Move Forward With Development of MedChew Rx Pharmaceutical Chewing Gum
May 02, 2017 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, May 02, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company’s product...
PharmaCyte Biotech's Dr. Mark Rabe Discusses the Significance of Schedule 1 License to Company's Future in Cannabis Research
June 18, 2015 09:00 ET
|
PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - June 18, 2015) - PharmaCyte Biotech (OTCQB: PMCB) announced this week that the Company is able to advance its Cannabis research now that its research partner, The...